Sustained Effectiveness or Inevitable Discontinuation? Five-Year Real-World Outcomes of Teriflunomide Therapy in Multiple Sclerosis
Loading...
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
Sage Publications Ltd
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Multiple Sclerosis Journal
Volume
31
Issue
3
Start Page
721
End Page
721
